1. Home
  2. FND vs NUVL Comparison

FND vs NUVL Comparison

Compare FND & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Floor & Decor Holdings Inc.

FND

Floor & Decor Holdings Inc.

HOLD

Current Price

$75.40

Market Cap

6.7B

ML Signal

HOLD

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$107.22

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FND
NUVL
Founded
2000
2017
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
7.1B
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
FND
NUVL
Price
$75.40
$107.22
Analyst Decision
Buy
Strong Buy
Analyst Count
17
15
Target Price
$82.12
$135.00
AVG Volume (30 Days)
2.6M
549.9K
Earning Date
02-19-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
11.08
N/A
EPS
2.00
N/A
Revenue
$4,661,833,000.00
N/A
Revenue This Year
$6.22
N/A
Revenue Next Year
$7.82
N/A
P/E Ratio
$38.32
N/A
Revenue Growth
6.04
N/A
52 Week Low
$55.11
$55.54
52 Week High
$108.76
$112.88

Technical Indicators

Market Signals
Indicator
FND
NUVL
Relative Strength Index (RSI) 72.46 56.46
Support Level $63.05 $97.43
Resistance Level $63.82 $108.46
Average True Range (ATR) 3.04 4.59
MACD 1.59 0.21
Stochastic Oscillator 88.82 90.39

Price Performance

Historical Comparison
FND
NUVL

About FND Floor & Decor Holdings Inc.

Floor & Decor Holdings Inc operates as a specialty retailer in the hard surface flooring market. Its stores offer a range of tile, wood, laminate, and natural stone flooring products, as well as decorative and installation accessories at everyday low prices. It appeals to a variety of customers including professional installers, commercial businesses, Do It Yourself (DIY) customers, and customers who buy the products for professional installation. Geographically, the group has a presence in the United States region and also offers its product through an e-commerce site.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: